{"summary":"Over 2 decades involvement in oncology and over 1 decade in industry oncology drug development with a deep breadth of experience in CAR T, CD3 bispecifics, and ADCs. Demonstrated leadership experience leading large clinical development teams in pharma. Experience developing high level clinical strategy and also acting as medical monitor leading phase 1 and phase 1b heme and solid tumor cancer clinical trials. Additional experience in late phase clinical development and early discovery. Ethical, collaborative and process-driven to deliver results and help patients with cancer.","lastName":"Kouros-Mehr, MD, PhD","objectUrn":"urn:li:member:173151177","geoRegion":"Los Angeles Metropolitan Area","fullName":"Hosein Kouros-Mehr, MD, PhD","firstName":"Hosein","currentPositions":[{"companyName":"TriArm Therapeutics","title":"VP Oncology, Head of US Clinical Development","tenureAtCompany":{"numMonths":2},"companyUrnResolutionResult":{"employeeCountRange":"51-200","website":"https:\/\/www.triarm.com\/","flagshipCompanyUrl":"https:\/\/www.linkedin.com\/company\/triarm-therapeutics\/","industry":"Biotechnology Research"},"startedOn":{"month":4,"year":2024},"companyUrn":"urn:li:fs_salesCompany:101721663"}],"entityUrn":"urn:li:fs_salesProfile:(ACwAAApSE8kBOPig3vWMUiCW2UOjHC-59bcTVKk,NAME_SEARCH,WBJP)","profilePictureDisplayImage":{"artifacts":[{"width":100,"fileIdentifyingUrlPathSegment":"100_100\/0\/1695351044264?e=1723075200&v=beta&t=MfNZ6DtkN-xfWPp1Wu7OcbR-waabfVv_ewqJcDEOpEQ","height":100},{"width":200,"fileIdentifyingUrlPathSegment":"200_200\/0\/1695351044264?e=1723075200&v=beta&t=cjrdS2P5cin7WmKJ7r07Ggq64URzwhanKGuE5v5agDM","height":200},{"width":400,"fileIdentifyingUrlPathSegment":"400_400\/0\/1695351044264?e=1723075200&v=beta&t=jzOw4PR3xOI8DLhLM7H3m6rmgp6BfU2Pc-zQn_XEI3U","height":400},{"width":800,"fileIdentifyingUrlPathSegment":"800_800\/0\/1695351044264?e=1723075200&v=beta&t=_JQ0bRpVPzXXC_V0r-WOfn_oaxmlL__4G_lviFBhMog","height":800}],"rootUrl":"https:\/\/media.licdn.com\/dms\/image\/D5603AQHlCSX0SdDfUg\/profile-displayphoto-shrink_"},"projects":[],"contactInfo":{},"industry":"Biotechnology Research","educations":[{"endedOn":{"year":2008},"degree":"Doctor of Medicine (M.D.)","eduId":102920082,"schoolUrn":"urn:li:fs_salesSchool:3028","school":"urn:li:fs_salesSchool:3028","fieldsOfStudy":["Medicine"],"schoolName":"University of California, San Francisco","startedOn":{"year":2001}},{"endedOn":{"year":2006},"degree":"Doctor of Philosophy (PhD)","eduId":102920155,"schoolUrn":"urn:li:fs_salesSchool:3028","school":"urn:li:fs_salesSchool:3028","fieldsOfStudy":["Biomedical Sciences, General"],"schoolName":"University of California, San Francisco","startedOn":{"year":2003}},{"endedOn":{"year":2000},"degree":"Bachelor of Science (B.S.)","eduId":102945434,"schoolUrn":"urn:li:fs_salesSchool:4992","school":"urn:li:fs_salesSchool:4992","fieldsOfStudy":["Biology, General"],"schoolName":"California Institute of Technology","startedOn":{"year":1997}}],"skills":[{"numOfEndorsement":11,"name":"Breast Cancer"},{"numOfEndorsement":28,"name":"Cancer Research"},{"numOfEndorsement":34,"name":"Molecular Biology"},{"numOfEndorsement":36,"name":"Cell Biology"},{"numOfEndorsement":2,"name":"Bioinformatics"},{"numOfEndorsement":2,"name":"Genomics"},{"numOfEndorsement":7,"name":"Stem Cells"},{"numOfEndorsement":5,"name":"Cell Signaling"},{"numOfEndorsement":2,"name":"Medical Research"},{"numOfEndorsement":4,"name":"Clinical Research"},{"numOfEndorsement":3,"name":"In Vivo"},{"numOfEndorsement":1,"name":"Western Blotting"},{"numOfEndorsement":1,"name":"In Vitro"},{"numOfEndorsement":4,"name":"Mouse Models"},{"numOfEndorsement":1,"name":"Translational Research"},{"numOfEndorsement":11,"name":"Drug Development"},{"numOfEndorsement":7,"name":"Drug Discovery"},{"numOfEndorsement":8,"name":"Cell"},{"numOfEndorsement":2,"name":"Assay Development"},{"numOfEndorsement":6,"name":"Biochemistry"},{"numOfEndorsement":1,"name":"qPCR"},{"numOfEndorsement":6,"name":"Cell Culture"},{"numOfEndorsement":1,"name":"Antibodies"},{"numOfEndorsement":2,"name":"Signal Transduction"},{"numOfEndorsement":1,"name":"Biomarkers"},{"numOfEndorsement":1,"name":"Animal Models"},{"numOfEndorsement":1,"name":"ELISA"},{"numOfEndorsement":7,"name":"Cancer"},{"numOfEndorsement":1,"name":"Flow Cytometry"},{"numOfEndorsement":4,"name":"Biotechnology"},{"numOfEndorsement":1,"name":"Immunohistochemistry"},{"numOfEndorsement":1,"name":"Transfection"},{"numOfEndorsement":1,"name":"Tissue Culture"},{"numOfEndorsement":1,"name":"Immunology"}],"numOfConnections":4482,"patents":[],"headline":"Committed to developing transformational cancer medicines","courses":[],"certifications":[],"memberBadges":{"premium":false,"openLink":false,"jobSeeker":false},"flagshipProfileUrl":"https:\/\/www.linkedin.com\/in\/hosein-kouros-mehr-md-phd-289ba349","organizations":[],"location":"Los Angeles Metropolitan Area","publications":[],"positions":null,"posts":[{"createdAt":1712103300000,"insightId":"3f4f3c3f-6130-45b9-9a22-5bd80eb23577","activityUnion":{"postActivity":{"contentSummaryUnion":{"referenceContentSummary":{"entityUrn":"urn:li:celebrateJobChange:7181081957831782401"}},"socialMetadata":{"reactionTypeCounts":[{"type":"PRAISE","count":59},{"type":"APPRECIATION","count":1},{"type":"LIKE","count":219},{"type":"EMPATHY","count":3}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:ugcPost:7181081958330900480","threadUrn":"urn:li:ugcPost:7181081958330900480","reactionsCount":282,"commentsCount":123,"canComment":true},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7181081958330900480","message":{"attributes":[{"start":16,"length":19,"value":{"com.linkedin.common.CompanyAttributedEntity":{"company":"urn:li:company:101721663"}}}],"text":"Excited to join TriArm Therapeutics as VP Oncology & Head of US Clinical Development. I look forward to building a team that will develop an innovative pipeline of CAR T cell therapies for patients with unmet medical needs. \n\nAt TriArm Therapeutics, we are advancing CAR T cell therapy innovation with new tools designed for more rapid CAR T cell manufacturing at a lower cost, thereby improving patient access and potentially enhancing safety and efficacy. Stay tuned as we advance an innovative pipeline designed to move the needle."},"entityUrn":"urn:li:ugcPost:7181081958330900480"}}},{"createdAt":1711289340000,"insightId":"8922d25f-9100-4199-96b4-e8f39f8e0e76","activityUnion":{"postActivity":{"contentSummaryUnion":{"mediaContentSummary":{"mediaType":"VIDEO","thumnailUrl":"https:\/\/dms.licdn.com\/playlist\/vid\/D5605AQFMJodMOBG1JQ\/videocover-firstframe-low\/0\/1711289345708?e=1717977600&v=beta&t=4dAfUdvuLbF44cLjb7e6pPfEu6d1q3zR78Jed9Bg810"}},"socialMetadata":{"reactionTypeCounts":[{"type":"LIKE","count":48}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:ugcPost:7177667738885087232","threadUrn":"urn:li:ugcPost:7177667738885087232","reactionsCount":48,"commentsCount":0,"canComment":true},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7177667738885087232","message":{"attributes":[{"start":22,"length":13,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:673574057"}}}],"text":"had a great time with Elliot Hasoon on his \"Simply Fit Podcast\" discussing the brain's 7 networks. you can watch full episode at yourdefaultmode (dot) com (under \"videos\")"},"entityUrn":"urn:li:ugcPost:7177667738885087232"}}},{"createdAt":1714189740000,"insightId":"82f0f905-5715-4c9e-879a-248c7a4e1b99","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[{"type":"LIKE","count":3}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(activity:7189643106923798530,7189832922869182464)","threadUrn":"urn:li:activity:7189643106923798530","reactionsCount":3,"commentsCount":0,"canComment":true},"commentary":{"attributes":[{"start":0,"length":19,"value":{"com.linkedin.common.CompanyAttributedEntity":{"company":"urn:li:company:101721663"}}}],"text":"TriArm Therapeutics is hiring"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:activity:7189643106923798530"}}}]}